# Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy

> **NCT00684905** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 50 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** bicalutamide
- **DRUG:** leuprolide acetate
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** neoadjuvant therapy
- **PROCEDURE:** quality-of-life assessment
- **RADIATION:** brachytherapy

## Key facts

- **NCT ID:** NCT00684905
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-04
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2012-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00684905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00684905, "Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00684905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*